A Comparison of Hallmark Mutations in Pediatric and Adult Brain Tumors

The WHO classification of brain tumors puts heavy emphasis on the molecular genetics that drive the pathogenesis of these tumors. It is still unclear if there are other genetic targets that could be targeted with novel therapies. We are interested in different genomic factors that drive the pathogenesis of these tumors in hopes of finding additional treatment of options that produce more favorable outcomes.